Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis
- 30 April 1980
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 23 (5) , 521-527
- https://doi.org/10.1002/art.1780230502
Abstract
Eighty‐eight patients with active rheumatoid arthritis from 8 Cooperating Clinics were evaluated in a 32‐week controlled, double‐blind trial comparing 150 mg daily to 75 mg cyclophosphamide daily. Improvement in the arthritis was seen in both grops, and there were no important differences between the two treatment groups in any of the 8 variables used to measure disease activity. Untoward effects were also similar for the two groups. These results differ from preliminary results reported earlier.This publication has 15 references indexed in Scilit:
- Controlled trial of cyclophosphamide in rheumatoid arthritisArthritis & Rheumatism, 1976
- Cyclophosphamide therapy for rheumatoid arthritisArchives of internal medicine (1960), 1975
- Neoplasia and CyclophosphamideArthritis & Rheumatism, 1973
- Double‐blind study of cyclophosphamide in rheumatoid arthritisArthritis & Rheumatism, 1973
- Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexateArthritis & Rheumatism, 1973
- STERILITY AND CYCLOPHOSPHAMIDEThe Lancet, 1972
- STERILITY AND TESTICULAR ATROPHY RELATED TO CYCLOPHOSPHAMIDE THERAPYThe Lancet, 1972
- Repeated Significance Tests on Accumulating DataJournal of the Royal Statistical Society. Series A (General), 1969
- Long‐term cyclophosphamide therapy in rheumatoid arthritisArthritis & Rheumatism, 1968
- A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritisArthritis & Rheumatism, 1965